Hogan Lovells

Delivering ‘legal research that is usable from a business standpoint’, the small but experienced team at Hogan Lovells has impressive life sciences credentials and expertise in industries including pharma, health care, consumer goods, chemicals, and technology; and advises on matters including M&A transactions, the restructuring of business models and operations, labelling and advertising issues, the launch of new products, product liability and antitrust, as well as handling litigation. Recent matters include regulatory advice to ensure full compliance with labelling requirements (under the amendments to NOM-051) and sanitary control regulations for products, services and advertising; operational regulatory advice; administrative litigation to secure product marketing authorisations; and assisting clients with navigation through public procurement procedures, among others. The practice is led by Ernesto Algaba Reyes, a 20-year veteran in the sector who focuses primarily on health law and regulatory compliance matters for the pharmaceutical and medical devices industries. Specialist support is provided by counsel Cecilia Stahlhut Espinosa who also has over 10 years’ sector experience regarding regulatory drug matters, medical devices, biotechnology, product compliance and general health regulatory compliance, as well as a background in related international trade matters. On the contentious front, the pair can call on counsel for global regulation, Alan Ramirez, and senior associates Giovanni Sosa (corporate and finance) and Marino Castillo (litigation and arbitration), as necessary; while on intellectual property-related mattes, practice head Bernardo Herrerías is the key contact. Former specialist associate Héctor Mercado moved to Cuesta Campos y Asociados S.C. in June 2022. Since publication, Stahlhut has been raised to the partnership - effective as of January 2024.